References
- 1. Miranda-Filho A, Piñeros M, Soerjomataram I, Deltour I, Bray F. Cancers of the brain and CNS: global patterns and trends in incidence. Neuro Oncol. 2017;19(2):270-280. https://doi.org/10.1093/neuonc/now166.546429227571887
- 2. National Brain Tumor Society. Current treatments for brain tumors. Natl. Brain Tumor Soc. 2017. Accessed from National brain tumor society. Current Treatments for Brain Tumors. https://braintumor.org/wp-content/assets/2017_NBTS_CurrentTreatmentOptions_083017.Pdf
- 3. Anam C, Soejoko DS, Haryanto F, Yani S, Dougherty G. Electron contamination for 6 MV photon beams from an Elekta linac: Monte Carlo simulation. Journal of Physics and Its Applications. 2020;2(2):97-101. https://doi.org/10.14710/jpa.v2i2.7771
- 4. Rusthoven KE, Pugh TJ. Stereotactic body radiation therapy for inoperable lung cancer. JAMA. 2010;303(23):2354-2355. https://doi.org/10.1001/jama.2010.77720551403
- 5. Lorentini S, Amelio D, Giri MG, et al. IMRT or 3D-CRT in glioblastoma? A dosimetric criterion for patient selection. Technol Cancer Res Treat. 2013;12(5):411-420. https://doi.org/10.7785/tcrt.2012.50034
- 6. Dunlop A, Welsh L, McQuaid D, et al. Brain-sparing methods for IMRT of head and neck cancer. PloS One. 2015;10(3):e0120141. https://doi.org/10.1371/journal.pone.0120141436453625781636
- 7. Herman TDLF, Ahmad S, Vlachaki MT. Intensity modulated radiation therapy versus three dimensional conformal radiation therapy for treatment of high grade glioma: a radiobiological modeling study. J Xray Sci Technol. 2010;18(4):393-402. https://doi.org/10.3233/XST-2010-027021045276
- 8. Yani S, Budiansah I, Pratama SH, Rhani MF, Anam C, Haryanto F. Evaluation of the dosimetric characteristics of 10 MV flattened and unflattened photon beams in a heterogeneous phantom. Int J Radiat Res. 2021;19(4):835-841. https://doi.org/10.29242/ijrr.19.4.835
- 9. Corkum MT, Mitchell S, Venkatesan V, Read N, Warner A, Palma DA. Does 5 + 5 equal better radiation treatment plans in head and neck cancers? Advances in Radiation Oncology. 2019;4(4):683-688. https://doi.org/10.1016/j.adro.2019.06.001681753331673661
- 10. Xhaferllari I, Wong E, Bzdusek K, Lock M, Chen JZ. Automated IMRT planning with regional optimization using planning scripts. J Appl Clin Med Phys. 2013;14(1):176-191. https://doi.org/10.1120/jacmp.v14i1.4052571404823318393
- 11. Wang D, Denittis A, Hu Y. Strategies to optimize stereotactic radiosurgery plans for brain tumors with volumetric-modulated arc therapy. J Appl Clin Med Phys. 2020;21(3):45-51. https://doi.org/10.1002/acm2.12818707538732043810
- 12. Jiménez-Puertas S, Sánchez-Artuñedo D, Hermida-López M. Assessment of the Monitor Unit Objective tool for VMAT in the Eclipse treatment planning system. Rep Pract Oncol Radiother. 2018;23(2):121-125. https://doi.org/10.1016/j.rpor.2018.02.001
- 13. Fogliata A, Reggiori G, Stravato A, et al. RapidPlan head and neck model: The objectives and possible clinical benefit. Radiat Oncol. 2017;12(1):73. https://doi.org/10.1186/s13014-017-0808-x
- 14. Fogliata A, Thompson S, Stravato A, Tomtis S, Scorsetti M, Cozzi L. On the gEUD biological optimization objective for organs at risk in Photon Optimizer of Eclipse treatment planning system. J Appl Clin Med Phys. 2018;19(1):106-114. https://doi.org/10.1002/acm2.12224
- 15. Varian Medical System. Eclipse photon and electron algorithms reference guide. Varian Medical Systems, Inc. 2015. 3100 Hansen Way Palo Alto, CA 94304-1038 United States of America
- 16. Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3):S10-S19. https://doi.org/10.1016/j.ijrobp.2009.07.1754
- 17. Antero AJ, Marika PK. Spatially-variant normal tissue objective for radiotherapy. Varian Medical Systems Int Ag (Ch). 2013; EP2038010. https://www.freepatentsonline.com/EP2038010B1.html
- 18. Cao T, Dai Z, Ding Z, Li W, Quan H. Analysis of different evaluation indexes for prostate stereotactic body radiation therapy plans: conformity index, homogeneity index and gradient index. Precision Radiation Oncology. 2019;3(3):72-79. https://doi.org/10.1002/pro6.1072
- 19. Lomax NJ, Scheib SG. Quantifying the degree of conformity in radiosurgery treatment planning. Int J Radiat Oncol Biol Phys. 2003;55(5):1409-1419. https://doi.org/10.1016/S0360-3016(02)04599-6
- 20. Shaw E, Kline R, Gillin M, et al. Radiation therapy oncology group: Radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys. 1993;27(5):1231-1239. https://doi.org/10.1016/0360-3016(93)90548-A
- 21. Paddick I, Lippitz B. A simple dose gradient measurement tool to complement the conformity index. J Neurosurg. 2006;105:194-201. https://doi.org/10.3171/sup.2006.105.7.19418503356
- 22. Ohtakara K, Hayashi S, Hoshi H. Dose gradient analyses in linac-based intracranial stereotactic radiosurgery using paddick’s gradient index: Consideration of the optimal method for plan evaluation. J Radiat Res. 2011;52(5):592-599. https://doi.org/10.1269/jrr.1100521768752
- 23. Sheng, K., Molloyb, J. A., Larnera, J. M., Reada P. W., 2007, A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer, Radiotherapy and Oncology, vol. 82(2), pp. 174-178, https://doi.org/10.1016/j.radonc.2007.01.00817275112
- 24. Rosenwald JC, Gaboriaud G, Pontvert D. La radiothhrapie conformationnelle principes et classification. Cancer/Radiothérapie. 1999;3(5):367-377. https://doi.org/10.1016/S1278-3218(00)87975-5
- 25. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47(2):291-298. https://doi.org/10.1016/s0360-3016(99)00507-6
- 26. Caldeira A, Trinca WC, Flores TP, et al. The influence of normal tissue objective in the treatment of prostate cancer. J Med Imag Radiat Sci. 2020;51(2):312-316. https://doi.org/10.1016/j.jmir.2020.02.00632327305
- 27. Bell J P, Patel P, Higgins K, McDonald MW, Roper J. Fine-tuning the normal tissue objective in Eclipse for lung stereotactic body radiation therapy. Med Dosim.2018;43(4):344-350. https://doi.org/10.1016/j.meddos.2017.11.00429277249
- 28. Xu L, Xu Y, Chen X, Xie X, Liang B, Dai J. A new homogeneity index definition for evaluation of radiotherapy plans. J Appl Clin Med Phys. 2019;20(11):50-56. https://doi.org/10.1002/acm2.12739683936531605454
- 29. Blonigen BJ, Steinmetz RD, Levin L, et al. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2010;77(4):996-1001. https://doi.org/10.1016/j.ijrobp.2009.06.00619783374
- 30. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol. 2006;81(1):18-24. https://doi.org/10.1016/j.radonc.2006.08.02416978720
- 31. Gong Y, Wang J, Bai S, Jiang X, Xu F. Conventionally-fractionated image-guided intensity modulated radiotherapy (IG-IMRT): A safe and effective treatment for cancer spinal metastasis. Radiat Oncol. 2008;3(11):1-10. https://doi.org/10.1186/1748-717X-3-11237379218426607
- 32. Eric JH. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65(1):1-7. https://doi.org/10.1016/j.ijrobp.2006.01.02716618572
- 33. Kry SF, Salehpour M, Followill DS, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62(4):1195-1203. https://doi.org/10.1016/j.ijrobp.2005.03.05315990025
- 34. Van Timmeren JE, Ehrbar S, Chamberlain M, et al. Single-isocenter versus multiple-isocenters for multiple lung metastases: evaluation of lung dose. Radiother Oncol. 2022;166:189-194. https://doi.org/10.1016/j.radonc.2021.11.03034864135